Benefits
Rapid onset of action suitable for intubation
Reliable skeletal muscle relaxation
Suitable for short to intermediate-duration procedures
Widely used in surgical and ICU settings
Manufactured under strict quality-controlled standards
Usage Instructions
Administered intravenously by trained anesthesia professionals only
Dosage depends on patient weight, clinical condition, and duration of procedure
Continuous monitoring of neuromuscular function is recommended
Mechanical ventilation support must be available during administration
Mechanism of Action
Rocuronium Bromide works by competitively blocking acetylcholine at nicotinic receptors at the neuromuscular junction. This prevents nerve impulse transmission to skeletal muscles, resulting in temporary muscle paralysis.
Indications
Rocuronium Bromide Injection 50 mg/5 mL is indicated for:
Adjunct to general anesthesia to facilitate tracheal intubation
Rapid sequence intubation (RSI)
Providing skeletal muscle relaxation during surgical procedures
Facilitating mechanical ventilation in intensive care settings
Side Effects
Possible side effects may include:
Hypotension
Tachycardia
Injection site reactions
Prolonged muscle weakness
Rare: Severe allergic or anaphylactic reactions
Precautions
Use only in settings with adequate airway management and resuscitation equipment
Monitor neuromuscular function to avoid prolonged blockade
Caution in patients with hepatic impairment or neuromuscular disorders
Dose adjustment may be required in elderly or critically ill patients
Reversal agents should be readily available
Contraindications
Known hypersensitivity to rocuronium bromide or other neuromuscular blocking agents
History of severe allergic reaction to bromide-containing compounds
Use without adequate facilities for airway management and ventilatory support